Insights into T cell recognition of antigen: Significance of two-dimensional kinetic parameters

Frontiers in Immunology

Volumn 3, Issue APR, 2012, Pages

  Edwards, Lindsay J ^a   Zarnitsyna, Veronika I ^b   Hood, Jennifer D ^a   Evavold, Brian D ^a   Zhu, Cheng ^b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Emory University   (United States)

Author keywords

2D binding,T cell activation; Affinity; Kinetics; Molecular interaction

Indexed keywords

EID: 84867413102     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2012.00086     Document Type: Review

References (54)

1. Adams, J. J., Narayanan, S., Liu, B., Birn-baum, M. E., Kruse, A. C., Bower-man, N. A., Chen, W., Levin, A. M., Connolly, J. M., Zhu, C., Kranz, D. M., and Garcia, K. C. (2011). T cell receptor signaling is limited by dock-ing geometry to peptide-major his-tocompatibility complex. Immunity 35, 681-693.
2. Alam, S. M., Davies, G. M., Lin, C. M., Zal, T., Nasholds, W., Jameson, S. C., Hogquist, K. A., Gascoigne, N. R., and Travers, P. J. (1999). Qualita-tive and quantitative differences in T cell receptor binding of agonist and antagonist ligands. Immunity 10, 227-237.
3. Alam, S. M., Travers, P. J., Wung, J. L., Nasholds, W., Redpath, S., Jameson, S. C., and Gascoigne, N. R. (1996). T-cell-receptor affinity and thymo-cyte positive selection. Nature 381, 616-620.
4. Altman, J. D., Moss, P. A. H., Goulder, P. J. R., Barouch, D. H., Mcheyzer-Williams, M. G., Mcmichael, A. J., and Davis, M. M. (1996). Phenotypic analysis of antigen-specific T lymphocytes. Science 274, 94-96.
5. Blattman, J. N., Grayson, J. M., Wherry, E. J., Kaech, S. M., Smith, K. A., and Ahmed, R. (2003). Therapeutic use of IL-2 to enhance antiviral T-cell responses in vivo. Nat. Med. 9, 540-547.
6. Boniface, J. J., Rabinowitz, J. D., Wulf-ing, C., Hampl, J., Reich, Z., Alt-man, J. D., Kantor, R. M., Beeson, C., Mcconnell, H. M., and Davis, M. M. (1998). Initiation of signal trans-duction through the T cell receptor requires the multivalent engagement of peptide/MHC ligands. Immunity 9, 459-466.
7. Burkhardt, J. K., Carrizosa, E., and Shaffer, M. H. (2008). The actin cytoskeleton in T cell activation. Annu. Rev. Immunol. 26, 233-259.
8. Chen, W., Evans, E. A., Mcever, R. P., and Zhu, C. (2008). Moni-toring receptor-ligand interactions between surfaces by thermal fluctu-ations. Biophys. J. 94, 694-701.
9. Chesla, S. E., Selvaraj, P., and Zhu, C. (1998). Measuring two-dimensional receptor-ligand binding kinetics by micropipette. Biophys. J. 75, 1553-1572.
10. Cochran, J. R., Cameron, T. O., Stone, J. D., Lubetsky, J. B., and Stern, L. J. (2001). Receptor proximity, not intermolecular orientation, is criti-cal for triggering T-cell activation. J. Biol. Chem. 276, 28068-28074.
11. Corr, M., Slanetz, A. E., Boyd, L. F., Jelonek,M. T.,Khilko,S.,Al-Ramadi, B. K., Kim, Y. S., Maher, S. E., Bothwell, A. L., and Margulies, D. H. (1994). T cell receptor-MHC class I peptide interactions: affinity, kinetics, and specificity. Science 265, 946-949.
12. Danke, N. A., and Kwok, W. W. (2003). HLA class II-restricted CD4+ T cell responses directed against influenza viral antigens postin-fluenza vaccination. J. Immunol. 171, 3163-3169.
13. Davis, M. M., Boniface, J. J., Reich, Z., Lyons, D., Hampl, J., Arden, B., and Chien,Y. (1998). Ligand recognition by alpha beta T cell receptors. Annu. Rev. Immunol. 16, 523-544.
14. Day, C. L., Seth, N. P., Lucas, M., Appel, H., Gauthier, L., Lauer, G. M., Rob-bins, G. K., Szczepiorkowski, Z. M., Casson, D. R., Chung, R. T., Bell, S., Harcourt, G., Walker, B. D., Klener-man, P., and Wucherpfennig, K. W. (2003). Ex vivo analysis of human memory CD4 T cells specific for hepatitis C virus using MHC class II tetramers. J. Clin. Invest. 112, 831-842.
15. Dustin, M. L., Bromley, S. K., Davis, M. M., and Zhu, C. (2001). Identification of self through two-dimensional chemistry and synapses. Annu.Rev.CellDev.Biol. 17, 133-157.
16. Evans, E., Ritchie, K., and Merkel, R. (1995). Sensitive force technique to probe molecular adhesion and struc-tural linkages at biological interfaces. Biophys. J. 68, 2580-2587.
17. Firbas, C., Jilma, B., Tauber, E., Buerger, V., Jelovcan, S., Lingnau, K., Buschle, M., Frisch, J., and Klade, C. S. (2006). Immunogenicity and safety of a novel therapeutic hepati-tis C virus (HCV) peptide vac-cine: a randomized, placebo con-trolled trial for dose optimization in 128 healthy subjects. Vaccine 24, 4343-4353.
18. Gakamsky, D. M., Luescher, I. F., Pra-manik, A., Kopito, R. B., Lemon-nier, F., Vogel, H., Rigler, R., and Pecht, I. (2005). CD8 kinetically promotes ligand binding to the T-cell antigen receptor. Biophys. J. 89, 2121-2133.
19. Germain, R. N., and Stefanova, I. (1999). The dynamics of T cell recep-tor signaling: complex orchestration and the key roles of tempo and coop-eration. Annu. Rev. Immunol. 17, 467-522.
20. Hernández, J., Lee, P. P., Davis, M. M., and Sherman, L. A. (2000). The use of HLA A2.1/p53 peptide tetramers to visualize the impact of self tol-erance on the TCR repertoire. J. Immunol. 164, 596-602.
21. Holmberg, K., Mariathasan, S., Ohteki, T., Ohashi, P. S., and Gascoigne, N. R. (2003). TCR binding kinet-ics measured with MHC class I tetramers reveal a positive select-ing peptide with relatively high affinity for TCR. J. Immunol. 171, 2427-2434.
22. Huang, J., Edwards, L. J., Evavold, B. D., and Zhu, C. (2007). Kinetics of MHC-CD8 interaction at the T cell membrane. J. Immunol. 179, 7653-7662.
23. Huang, J., Zarnitsyna, V. I., Liu, B., Edwards, L. J., Jiang, N., Evavold, B. D., and Zhu, C. (2010). The kinetics of two-dimensional TCR and pMHC interactions determine T-cell responsiveness. Nature 464, 932-936.
24. Huppa, J. B., Axmann, M., Mörtel-maier, M. A., Lillemeier, B. F., Newell, E. W., Brameshuber, M., Klein, L. O., Schütz, G. J., and Davis, M. M. (2010). TCR-peptide-MHC interactions in situ show acceler-ated kinetics and increased affinity. Nature 463, 963-967.
25. Janeway, C. A. Jr. (1992). The T cell receptor as a multicomponent sig-nalling machine: CD4/CD8 corecep-tors and CD45 in T cell activation. Annu. Rev. Immunol. 10, 645-674. [Review].
26. Jiang, N., Huang, J., Edwards, L. J., Liu, B., Zhang, Y., Beal, C. D., Evavold, B. D., and Zhu, C. (2011). Two-stage cooperative T cell receptor-peptide major histocompatibility complex-CD8 trimolecular interac-tions amplify antigen discrimina-tion. Immunity 34, 13-23.
27. Klopocki,A. G.,Yago,T.,Mehta,P.,Yang, J., Wu, T., Leppanen, A., Bovin, N. V., Cummings, R. D., Zhu, C., and Mcever, R. P. (2008). Replacing a lectin domain residue in L-selectin enhances binding to P-selectin gly-coprotein ligand-1 but not to 6-sulfo-sialyl Lewis x. J. Biol. Chem. 283, 11493-11500.
28. Krogsgaard, M., Prado, N., Adams, E. J., He, X. L., Chow, D. C., Wil-son, D. B., Garcia, K. C., and Davis, M. M. (2003). Evidence that struc-tural rearrangements and/or flexi-bility during TCR binding can con-tributetoTcellactivation.Mol. Cell 12, 1367-1378.
29. Laugel, B., van den Berg, H. A., Gostick, E., Cole, D. K., Wooldridge, L., Boul-ter, J., Milicic, A., Price, D. A., and Sewell, A. K. (2007). Different T cell receptor affinity thresholds and CD8 coreceptor dependence govern cyto-toxic T lymphocyte activation and tetramer binding properties. J. Biol. Chem. 282, 23799-23810.
30. Lee, K. H., Wang, E., Nielsen, M. B., Wunderlich, J., Migueles, S., Con-nors, M., Steinberg, S. M., Rosen-berg, S. A., and Marincola, F. M. (1999). Increased vaccine-specific T cell frequency after peptide-based vaccination correlates with increased susceptibility to in vitro stimulation but does not lead to tumor regression. J. Immunol. 163, 6292-6300.
31. Leishman, A. J., Naidenko, O. V., Attinger, A., Koning, F., Lena, C. J., Xiong, Y., Chang, H. C., Reinherz, E., Kronenberg, M., and Cheroutre, H. (2001). T cell responses mod-ulated through interaction between CD8alphaalpha and the nonclassical MHC class I molecule, TL. Science 294, 1936-1939.
32. Mancini-Bourgine, M., Fontaine, H., Scott-Algara, D., Pol, S., Brechot, C., and Michel, M. L. (2004). Induction or expansion of T-cell responses by a hepatitis B DNA vaccine adminis-tered to chronic HBV carriers. Hepa-tology 40, 874-882.
33. Matsui, K., Boniface, J. J., Steffner, P., Reay, P. A., and Davis, M. M. (1994). Kinetics of T-cell recep-tor binding to peptide/I-Ek com-plexes: correlation of the dissoci-ation rate with T-cell responsive-ness. Proc. Natl. Acad. Sci. U.S.A. 91, 12862-12866.
34. McKeithan, T. W. (1995). Kinetic proof-reading in T-cell receptor signal transduction. Proc. Natl. Acad. Sci. U.S.A. 92, 5042-5046.
35. Mehta,P.,Cummings,R. D.,and Mcever, R. P. (1998). Affinity and kinetic analysis of P-selectin binding to P-selectin glycoprotein ligand-1. J. Biol. Chem. 273, 32506-32513.
36. Pittet, M. J., Speiser, D. E., Lienard, D., Valmori, D., Guillaume, P., Dutoit, V., Rimoldi, D., Lejeune, F., Cerot-tini, J. C., and Romero, P. (2001a). Expansion and functional matu-ration of human tumor antigen-specific CD8+ T cells after vacci-nation with antigenic peptide. Clin. Cancer Res. 7, 796s-803s.
37. Pittet, M. J., Speiser, D. E., Valmori, D., Rimoldi, D., Lienard, D., Leje-une, F., Cerottini, J. C., and Romero, P. (2001b). Ex vivo analysis of tumor antigen specific CD8+ T cell responses using MHC/peptide tetramers in cancer patients. Int. Immunopharmacol. 1, 1235-1247.
38. Robert, P., Aleksic, M., Dushek, O., Cerundolo, V., Bongrand, P., and van der Merwe, A. (2012). Kinetics and mechanics of two-dimensional interactions between T cell recep-tors and different activating ligands. Biophys. J. 102, 248-257
39. Rosette, C., Werlen, G., Daniels, M. A., Holman, P. O., Alam, S. M., Tra-vers, P. J., Gascoigne, N. R., Palmer, E., and Jameson, S. C. (2001). The impact of duration versus extent of TCR occupancy on T cell acti-vation: a revision of the kinetic proofreading model. Immunity 15, 59-70.
40. Rudolph, M. G., and Wilson, I. A. (2002). The specificity of TCR/pMHC interaction. Curr. Opin. Immunol. 14, 52-65.
41. Sabatino, J. J., Huang, J., Zhu, C., and Evavold, B. D. (2011). High preva-lence of low affinity peptide-MHC II tetramer-negative effectors during polyclonal CD4+ T cell responses. J. Exp. Med. 208, 81-90.
42. Scriba, T. J., Purbhoo, M., Day, C. L., Robinson, N., Fidler, S., Fox, J., Weber, J. N., Klenerman, P., Sewell, A. K., and Phillips, R. E. (2005). Ultrasensitive detection and pheno-typing of CD4+ T cells with opti-mized HLA class II tetramer stain-ing. J. Immunol. 175, 6334-6343.
43. Stone, J. D., Artyomov, M. N., Chervin, A. S., Chakraborty, A. K., Eisen, H. N., and Kranz, D. M. (2011). Interaction of streptavidin-based peptide-MHC oligomers (Tetramers) with cell-surface TCRs. J. Immunol. 187, 6281-6290.
44. Thome, M., Duplay, P., Guttinger, M., and Acuto, O. (1995). Syk and ZAP-70 mediate recruitment of p56lck/CD4 to the activated T cell receptor/CD3/zeta complex. J. Exp. Med. 181, 1997-2006.
45. Tolentino, T. P., Wu, J., Zarnitsyna, V. I., Fang, Y., Dustin, M. L., and Zhu, C. (2008). Measuring diffusion and binding kinetics by contact area FRAP. Biophys. J. 95, 920-930.
46. van den Berg, H. A., Wooldridge, L., Laugel, B., and Sewell, A. K. (2007). Coreceptor CD8-driven modulation of T cell antigen receptor specificity. J. Theor. Biol. 249, 395-408.
47. van der Merwe, P. A. (2001). The TCR triggering puzzle. Immunity 14, 665-668.
48. van der Merwe, P. A., and Cordoba, S. P. (2011). Late arrival: recruiting coreceptors to the T cell receptor complex. Immunity 34, 1-3.
49. Wasserman, H. A., Beal, C. D., Zhang, Y., Jiang, N., Zhu, C., and Evavold, B. D. (2008). MHC variant peptide-mediated anergy of encephalitogenic T cells requires SHP-1. J. Immunol. 181, 6843-6849.
50. Wooldridge, L., van den Berg, H. A., Glick, M., Gostick, E., Laugel, B., Hutchinson, S. L., Milicic, A., Brenchley, J. M., Douek, D. C., Price, D. A., and Sewell,A. K. (2005). Inter-action between the CD8 coreceptor and major histocompatibility com-plex class I stabilizes T cell receptor-antigen complexes at the cell surface. J. Biol. Chem. 280, 27491-27501.
51. Wu, J., Fang, Y., Zarnitsyna, V. I., Tolentino, T. P., Dustin, M. L., and Zhu, C. (2008). A coupled diffusion-kinetics model for analysis of contact-area FRAP experiment. Biophys. J. 95, 910-919.
52. Xu, H., and Littman, D. R. (1993). A kinase-independent function of Lck in potentiating antigen-specific T cell activation. Cell 74, 633-643.
53. Zarnitsyna, V. I., Huang, J., Zhang, F., Chien, Y. H., Leckband, D., and Zhu, C. (2007). Memory in receptor-ligand-mediated cell adhe-sion. Proc. Natl. Acad. Sci. U.S.A. 104, 18037-18042.
54. Zhang, F., Marcus, W. D., Goyal, N. H., Selvaraj, P., Springer, T. A., and Zhu, C. (2005). Two-dimensional kinetics regulation of alphaLbeta2-ICAM-1 interaction by conformational changes of the alphaL-inserted domain. J. Biol. Chem. 280, 42207-42218.